is a glp-1 insulin Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research – Caltag Medsystems GLP-1R and Diabetes

In a study involving 10 healthy male subjects, GIP infusion more than doubled the insulin secretion rate compared to the placebo group when the glucose was maintained at 216 mg/dL (119)

Obesity and Cardiovascular Disease

Empagliflozin and dapagliflozin are TGA approved for heart failure independent of ejection fraction or diabetes status and are PBS listed for heart failure with reduced ejection fraction (HFrEF, with left ventricular ejection fraction 40%)

But let's catch everyone else up to speed on some of the most common side effects of GLP-1s and any long-term risks

It may include nutrition guidance, lifestyle support, and treatments such as NAD+ injection therapy or other vitamin injections to support overall health and weight management

Identifying major depression using whole-brain functional connectivity: a multivariate pattern analysis